West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC decreased its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 2.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,954 shares of the medical instruments supplier’s stock after selling 253 shares during the period. Mutual of America Capital Management LLC’s holdings in West Pharmaceutical Services were worth $2,688,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Paragon Advisors LLC boosted its holdings in shares of West Pharmaceutical Services by 2.0% in the third quarter. Paragon Advisors LLC now owns 6,804 shares of the medical instruments supplier’s stock valued at $2,042,000 after acquiring an additional 136 shares in the last quarter. Natixis Advisors LLC raised its position in shares of West Pharmaceutical Services by 9.7% during the third quarter. Natixis Advisors LLC now owns 53,747 shares of the medical instruments supplier’s stock worth $16,133,000 after purchasing an additional 4,740 shares during the period. Mizuho Securities USA LLC raised its holdings in West Pharmaceutical Services by 277.1% during the 3rd quarter. Mizuho Securities USA LLC now owns 21,173 shares of the medical instruments supplier’s stock worth $6,355,000 after buying an additional 15,559 shares during the period. Mizuho Markets Americas LLC lifted its position in shares of West Pharmaceutical Services by 9.4% in the 3rd quarter. Mizuho Markets Americas LLC now owns 17,420 shares of the medical instruments supplier’s stock valued at $5,229,000 after acquiring an additional 1,497 shares in the last quarter. Finally, Empowered Funds LLC lifted its holdings in shares of West Pharmaceutical Services by 3.9% in the third quarter. Empowered Funds LLC now owns 1,377 shares of the medical instruments supplier’s stock valued at $413,000 after purchasing an additional 52 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

West Pharmaceutical Services Stock Down 1.3 %

NYSE:WST opened at $316.59 on Friday. The business’s fifty day moving average price is $307.01 and its 200 day moving average price is $314.28. The firm has a market capitalization of $22.93 billion, a price-to-earnings ratio of 46.97, a PEG ratio of 24.24 and a beta of 1.00. The company has a current ratio of 3.00, a quick ratio of 2.23 and a debt-to-equity ratio of 0.07. West Pharmaceutical Services, Inc. has a 1-year low of $265.00 and a 1-year high of $413.70.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.50 by $0.35. The company had revenue of $746.90 million for the quarter, compared to analysts’ expectations of $709.62 million. West Pharmaceutical Services had a return on equity of 18.41% and a net margin of 17.37%. The business’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.16 EPS. On average, sell-side analysts forecast that West Pharmaceutical Services, Inc. will post 6.67 earnings per share for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 20th. Shareholders of record on Wednesday, November 13th were given a $0.21 dividend. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date was Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. West Pharmaceutical Services’s dividend payout ratio is presently 12.46%.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 703 shares of West Pharmaceutical Services stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $310.40, for a total transaction of $218,211.20. Following the completion of the sale, the vice president now directly owns 1,253 shares in the company, valued at $388,931.20. The trade was a 35.94 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.53% of the company’s stock.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.